Equity Overview
Price & Market Data
Price: $12.50
Daily Change: $0.00 / 0.00%
Range: $12.48 - $12.65
Market Cap: $148,812,496
Volume: 55,606
Performance Metrics
1 Week: -4.65%
1 Month: -11.85%
3 Months: -17.38%
6 Months: 65.13%
1 Year: 158.8%
YTD: 39.82%
Company Details
Employees: 140
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.